(E. Marchi and L. Montecchi, US Patent 4341785, 27 July 1982.)
5. The emergence of MDR-TB is becoming a significant clinical problem. Describe the mechanism by which bacteria become resistant to rifampicin.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
